000			01893 a2200493 4500
005			20250516214653.0
264		0	_c20150219
008			201502s 0 0 eng d
022			_a1745-6215
024	7		_a10.1186/1745-6215-15-159 _2doi
040			_aNLM _beng _cNLM
100	1		_aSnow, Kristin K
245	0	0	_aProcesses to manage analyses and publications in a phase III multicenter randomized clinical trial. _h[electronic resource]
260			_bTrials _cMay 2014
300			_a159 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aClinical Trials Data Monitoring Committees _xstandards
650	0	4	_aData Interpretation, Statistical
650	0	4	_aDrug Therapy, Combination
650	0	4	_aGuideline Adherence _xstandards
650	0	4	_aGuidelines as Topic _xstandards
650	0	4	_aHepatitis C _xdiagnosis
650	0	4	_aHumans
650	0	4	_aInformation Dissemination
650	0	4	_aInterferon-alpha _xtherapeutic use
650	0	4	_aManuscripts, Medical as Topic
650	0	4	_aPeer Review, Research _xstandards
650	0	4	_aPeriodicals as Topic _xstandards
650	0	4	_aPolyethylene Glycols _xtherapeutic use
650	0	4	_aRecombinant Proteins _xtherapeutic use
650	0	4	_aResearch Design _xstandards
650	0	4	_aRibavirin _xtherapeutic use
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
700	1		_aBell, Margaret C
700	1		_aStoddard, Anne M
700	1		_aCurto, Teresa M
700	1		_aWright, Elizabeth C
700	1		_aDienstag, Jules L
773	0		_tTrials _gvol. 15 _gp. 159
856	4	0	_uhttps://doi.org/10.1186/1745-6215-15-159 _zAvailable from publisher's website
999			_c23877818 _d23877818